Zentalis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.
ZNTL Key Statistics
Stock Snapshot
The current Zentalis Pharmaceuticals(ZNTL) stock price is $2.36, with a market capitalization of 172.68M. The stock trades at a price-to-earnings (P/E) ratio of -1.15.
During the trading session on 2026-03-01, Zentalis Pharmaceuticals(ZNTL) shares reached a daily high of $2.51 and a low of $2.36. At a current price of $2.36, the stock is +0.2% higher than the low and still -6.0% under the high.
Trading volume for Zentalis Pharmaceuticals(ZNTL) stock has reached 496.69K, versus its average volume of 678.28K.
The stock's 52-week range extends from a low of $1.01 to a high of $3.95.
The stock's 52-week range extends from a low of $1.01 to a high of $3.95.
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.